Campbell Rogers
CIK 1585724 · Chief Medical Officer · last filed 2026-08-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$4.05M
Companies
6
Total Filings
38
Lifetime Open-Market Net
-$5.34M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HTFL | Chief Medical Officer | 137,213 | $29.54 | $4.05M | -$5.34M | 11 | 2026-08-10 |
| InspireMD, Inc. (NSPRZ) Delisted | Director | 27,960 | $0.01 | $252 | $0 | 1 | 2021-10-14 |
| InspireMD, Inc. (NSPR.WS.B) Delisted | Director | 160,635 | $0.03 | $4.8K | $0 | 2 | 2020-09-02 |
| Corindus Vascular Robotics, Inc. (CVRS) Delisted | Director | 90,149 | — | — | $0 | 7 | 2019-05-07 |
| InspireMD, Inc. (NSPR.WS) Delisted | Director | — | $0.05 | — | $0 | 1 | 2016-12-09 |
| NSPR | Director | 0 | $0.85 | $0 | $5.0K | 10 | 2016-07-05 |
Recent Filings · Page 2 of 4
38 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-19 | HTFL | Notice (144) | −64,533 | -$1.66M | EDGAR |
| 2026-02-17 | HTFL | Mixed | +1,863 | -$1.20M | EDGAR |
| 2026-02-12 | HTFL | Notice (144) | −65,153 | -$1.60M | EDGAR |
| 2026-02-10 | HTFL | Mixed | +53,558 | -$14.3K | EDGAR |
| 2025-11-12 | HTFL | Tax (F) | −439 | -$14.3K | EDGAR |
| 2025-08-11 | HTFL | Grant (A) | +21,052 | $0 | EDGAR |
| 2021-10-14 | InspireMD, Inc. (NSPRZ) Delisted | Grant (A) | +17,248 | $0 | EDGAR |
| 2020-09-02 | InspireMD, Inc. (NSPR.WS.B) Delisted | Grant (A) | +158,033 | $0 | EDGAR |
| 2019-10-31 | — | Disp (D) | −90,149 | -$385.8K | |
| 2019-05-07 | Corindus Vascular Robotics, Inc. (CVRS) Delisted | Grant (A) | +27,649 | $60.0K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.